Publications by authors named "Matilde Bocci"

Claim this Profile
D
Development of Multivalent FAP-Targeted Small Molecule-Drug Conjugates with Tailored MMAE Release Kinetics.
Matilde Bocci, Lucrezia Principi, Dario Neri, Samuele Cazzamalli, Ettore Gilardoni

Mol Cancer Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein.
Giulia Rotta, Eleonora Prodi, Frauke Seehusen, Matilde Bocci, Francesco Prisco

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics.
Andrea Galbiati, Matilde Bocci, Dario Neri, Samuele Cazzamalli

Eur J Nucl Med Mol Imaging· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule-Drug Conjugates Elicits Potent Anticancer Activity.
Matilde Bocci, Lucrezia Principi, Ettore Gilardoni, Dario Neri, Samuele Cazzamalli

Bioconjug Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors.
Andrea Galbiati, Matilde Bocci, Domenico Ravazza, Jacqueline Mock, Ettore Gilardoni

J Nucl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention.
Andrea Galbiati, Matilde Bocci, Silvia Gervasoni, Eleonora Prodi, Giuliano Malloci

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-encoded chemical libraries enable the discovery of potent PSMA-ligands with substantially reduced affinity towards the GCPIII anti-target.
Laura Lucaroni, Sebastian Oehler, Tony Georgiev, Marco Müller, Matilde Bocci

Chem Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment.
Matilde Bocci, Aureliano Zana, Lucrezia Principi, Laura Lucaroni, Luca Prati

J Control Release· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics.
Andrea Galbiati, Paulina Dorten, Ettore Gilardoni, Florian Gierse, Matilde Bocci

J Nucl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker.
Lydia Bisbal Lopez, Domenico Ravazza, Matilde Bocci, Aureliano Zana, Lucrezia Principi

Front Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule-Drug, Antibody-Drug, and Peptide-Drug Conjugates.
Aureliano Zana, Claudia Puig-Moreno, Matilde Bocci, Ettore Gilardoni, Cesare Di Nitto

Bioconjug Chem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake.
Andrea Galbiati, Aureliano Zana, Matilde Bocci, Jacopo Millul, Abdullah Elsayed

J Nucl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors.
Aureliano Zana, Andrea Galbiati, Ettore Gilardoni, Matilde Bocci, Jacopo Millul

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis